(Q73300381)
Statements
Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study (English)
P Hoskins
E Eisenhauer
J Dubuc-Lissoir
B Fisher
R Grimshaw
A Oza
M Plante
G Stuart